NCT01370707 - A Study to Evaluate the Efficacy and Safety of CJ-30001 and CJ-30002 in Type 2 Diabetes Mellitus Patients | Biotech Hunter

Enrollment

187

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions

Diabetes Mellitus

Interventions

DRUG

Metformin

1000\~1500mg/day, 24weeks

DRUG

CJ-30001/CJ-30002

0.6/1500mg\~0.9/1500mg/day, 24weeks

Trial Locations (21)

Bucheon St. Mary's Hospital, Bucheon-si

Seoul National University Bundang Hospital, Bundang

Kyungpook University Hospital, Daegu

Yeungnam University Medical Center, Daegu

National Health Insurance Coporation Ilsan Hospital, Ilsan

Inha University Hospital, Incheon

Chonbuk National University Hospital, Jeonju

Inje University Pusan Baik Hospital, Pusan

Pusan National University Hospital, Pusan

Asan Medical Center, Seoul

Eulji Medical Center, Seoul

Hallym University Medical Center(Gangdong), Seoul

Hallym University Medical Center(Gangnam), Seoul

Kangbuk Samsung Hospital, Seoul

Korea University Guro Hospital, Seoul

Kyung Hee University Hospital, Seoul

Samsung Medical Center, Seoul

Seoul St. Mary's hospital, Seoul

Severance Hospital, Seoul

Ajou University Hospital, Suwon

Uijeongbu St. Mary's Hospital, Uijeongbu-si